Oral GLP1 Gene Delivery by an Antibody-Guided Nanomaterial to Treat Type 2 Diabetes Mellitus

糖尿病 新生儿Fc受体 低血糖 肠促胰岛素 内科学 抗体 内分泌学 胰岛素 2型糖尿病 纳米载体 胰岛 医学 药理学 2型糖尿病 生物 小岛 免疫学 免疫球蛋白G 药品
作者
Mohammad Nazmul Hasan,Yong Hwa Hwang,Jeong Man An,S. M. Shatil Shahriar,Sungpil Cho,Yong-Kyu Lee
出处
期刊:ACS Applied Materials & Interfaces [American Chemical Society]
卷期号:12 (35): 38925-38935 被引量:12
标识
DOI:10.1021/acsami.0c09814
摘要

Type 2 diabetes mellitus (T2DM) is a chronic and progressive hyperglycemic condition. Glucagon-like peptide-1 (GLP1) is an incretin secreted from pancreatic β-cells and helps to produce insulin to balance the blood glucose level without the risk of hypoglycemia. However, the therapeutic application of GLP1 is limited by its intrinsic short half-life and rapid metabolic clearance in the body. To enhance the antidiabetic effect of GLP1, we designed a human cysteine-modified IgG1-Fc antibody-mediated oral gene delivery vehicle, which helps to produce GLP1 sustainably in the target site with the help of increased half-life of the Fc-conjugated nanocarrier, protects GLP1 from acidic and enzymatic degradation in the gastrointestinal (GI) tract, uptakes and transports the GLP1 formulation through the neonatal Fc receptor (FcRn), and helps to release the GLP1 gene in the intestine. Our formulation could reduce the blood glucose from about an average of 320 mg/dL (hyperglycemic) to 150 mg/dL (normal blood glucose concentration) in diabetic mice, which is about 50% reduction of the total blood glucose concentration. GLP1 (500 μg) complexed with the IgG1-Fc carrier was proven to be the optimal dose for a complete reduction of hyperglycemic conditions in diabetic mice. A significant amount of insulin production and the presence of GLP1 peptide were observed in the pancreatic islets of oral GLP1 formulation-treated diabetic mice in immunohistochemistry analysis compared to nontreated diabetic mice. The orally given formulation was completely nontoxic according to the histopathology analysis of mice organ tissues, and no mice death was observed. Our antibody-mediated oral gene delivery system is a promising tool for various oral therapeutic gene delivery applications to treat diseases like diabetes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小二郎的应助被hua采纳,获得10
刚刚
Jasper的应助被hua采纳,获得10
刚刚
天天快乐的应助被hua采纳,获得10
刚刚
我是老大的应助被hua采纳,获得10
1秒前
隐形曼青的应助被hua采纳,获得10
1秒前
共享精神的应助被hua采纳,获得10
1秒前
炙热之霜完成签到,获得积分10
1秒前
在水一方的应助被hua采纳,获得10
1秒前
在水一方的应助被hua采纳,获得10
1秒前
852的应助被hua采纳,获得10
1秒前
脑洞疼的应助被hua采纳,获得10
1秒前
1秒前
深情安青的应助被adasda采纳,获得10
2秒前
江随烨发布了新的文献求助10
2秒前
PZL完成签到,获得积分10
3秒前
哈哈哈哈发布了新的文献求助10
3秒前
3秒前
dyhhh完成签到 ,获得积分10
3秒前
3秒前
4秒前
4秒前
4秒前
源宥冰发布了新的文献求助10
5秒前
科研通AI65的应助被卓卓卓采纳,获得10
5秒前
ouoii3完成签到,获得积分10
5秒前
正直无极完成签到,获得积分10
7秒前
heeh发布了新的文献求助10
8秒前
乐鱼发布了新的文献求助10
8秒前
张莹发布了新的文献求助30
8秒前
8秒前
double_manager的应助被Gxt采纳,获得10
8秒前
zyy发布了新的文献求助10
9秒前
9秒前
zan12131发布了新的文献求助30
9秒前
义气傲薇发布了新的文献求助10
10秒前
11秒前
11秒前
helping完成签到 ,获得积分10
11秒前
苏邑发布了新的文献求助10
11秒前
长风赴宴完成签到 ,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181379
求助须知:如何正确求助?哪些是违规求助? 9571317
关于积分的说明 21817457
捐赠科研通 7777820
什么是DOI,文献DOI怎么找? 3433454
关于科研通互助平台的介绍 2557692
邀请新用户注册赠送积分活动 2479523